Kamala Harris

Joe Biden

Dean Phillips

Marianne Williamson

Donald Trump

Vivek Ramaswamy

Nikki Haley

Ron DeSantis

Cornel West

Robert F. Kennedy

2024 United States Presidential Election

AUSTIN, Texas, July  23, 2024  (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report second quarter 2024 financial results after the market close on Thursday, August 1, 2024. The company will host a conference call and webcast at 4:30pm ET that day to discuss these financial results and provide an update on clinical and corporate activities…

Benzinga

New York

United States

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - Lumos Pharma (NASDAQ:LUMO)

Ad Fontes Media

Media Bias/Fact Check

MINNEAPOLIS, July  23, 2024  (GLOBE NEWSWIRE) — Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), a …

Financial Post

Leon Cooperman

Allianz

Canada

Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024

PLYMOUTH MEETING, PA — AdaptHealth Corp. will disclose its financial results for the second quarter of 2024 before the financial markets open on Tuesday, August 6, 2024. The company has scheduled a teleconference at 8:30 a.m. ET to discuss the results and ongoing business activities with analysts and investors. Participants can join the call by dialing (800) 343-4136 for domestic callers or (203) 518-9843 for international callers. When prompted…

MyChesCo

AdaptHealth Set to Announce Second Quarter Financial Results

EMERYVILLE, Calif., July 23, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2024 financial results on Tuesday, August 6, 2024, after the U.S. financial markets close.

Gilbert Sun News

Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024

Calgary, Alberta--(Newsfile Corp. - July 23, 2024) - Suncor (TSX: SU) (NYSE: SU) will release its second quarter financial results on

Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024 - Lumos Pharma (NASDAQ:LUMO)

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics